Morningstar's BBS-Bioactive Bone Substitutes PLC Ordinary Shares Stock Analysis
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Company Profile - BONEH
BBS-Bioactive Bone Substitutes PLC is a health technology company, that develops, designs, and manufactures innovative bioactive bone-graft substitute implants. Its ortho biological product ARTEBONE, which is based on tricalcium phosphate and a natural spectrum of bone proteins has the capability of bone regeneration.
Oulu, 90220, Finland